<p> Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.</p>

Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.

The Amyloid Hypothesis for Alzheimer Disease and Aducanumab

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Share The Amyloid Hypothesis for Alzheimer Disease and Aducanumab

Sign up to save your podcasts

The Amyloid Hypothesis for Alzheimer Disease and Aducanumab

The Amyloid Hypothesis for Alzheimer Disease and Aducanumab

More shows like Neurology® Podcast

JAMA Editors' Summary

NEJM This Week

Practical Neurology Podcast

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

JAMA Neurology Author Interviews

Core IM | Internal Medicine Podcast

Neurology Today in 5

Annals On Call Podcast

The Clinical Problem Solvers

Neurology Minute

Harrison's PodClass: Internal Medicine Cases and Board Prep

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio